Hostname: page-component-848d4c4894-jbqgn Total loading time: 0 Render date: 2024-07-07T03:01:57.487Z Has data issue: false hasContentIssue false

Acute Cyanide Poisoning in Prehospital Care: New Challenges, New Tools for Intervention

Published online by Cambridge University Press:  28 June 2012

Tee Guidotti*
Affiliation:
Professor and Director, Division of Occupational Medicine and Toxicology, Department of Medicine, School of Medicine and Health Sciences, The George Washington University Medical Center, Washington, DC, USA
*
Correspondence: E-mail: eohtlg@gwumc.edu

Abstract

Effective management of cyanide poisoning from chemical terrorism, inhalation of fire smoke, and other causes constitutes a critical challenge for the pre-hospital care provider. The ability to meet the challenge of managing cyanide poisoning in the prehospital setting may be enhanced by the availability of the cyanide antidote hydroxocobalamin, currently under development for potential introduction in the United States. This paper discusses the causes, recognition, and management of acute cyanide poisoning in the prehospital setting with emphasis on the emerging profile of hydroxocobalamin, an antidote that may have a risk:benefit ratio suitable for empiric, out-of-hospital treatment of the range of causes of cyanide poisoning. If introduced in the US, hydroxocobalamin may enhance the role of the US prehospital responder in providing emergency care in a cyanide incident.

Type
Comprehensive Review
Copyright
Copyright © World Association for Disaster and Emergency Medicine 2006

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1Sauer, SW, Keim, ME: Hydroxocobalamin: Improved public health readiness for cyanide disasters. Ann Emerg Med 2001;37:635641.CrossRefGoogle ScholarPubMed
2Hall, AH, Walsh, D, Maniscalco, P: Hydroxocobalamin as a cyanide antidote in prehospital first responder care. JEMS 2004;20(suppl):Abstract.Google Scholar
3Keim, ME, Pesik, N, Twum-Danso, NA: Lack of hospital preparedness for chemical terrorism in a major US city: 1996–2000. Prehosp Disast Med 2003;18:193199.CrossRefGoogle Scholar
4Ciraulo, DL, Frykberg, ER, Feliciano, DV et al. , : A survey assessment of the level of preparedness for domestic terrorism and mass casualty incidents among Eastern Association for the Surgery of Trauma members. J Trauma 2004;56:10331039.CrossRefGoogle ScholarPubMed
5Cummings, TF: The treatment of cyanide poisoning. Occup Med 2004;54:8285.CrossRefGoogle ScholarPubMed
6Keim, ME: Cyanide and chemical terrorism. Prehosp Disast Med 2006;21(S2yes):s56s60.CrossRefGoogle Scholar
7Eckstein, M: Focus on smoke inhalation—The most common cause of acute cyanide poisoning. Prehosp Disast Med 2006;21(S2yes):s49s55.CrossRefGoogle ScholarPubMed
8Gossel, TA, Bricker, JD: Principles of Clinical Toxicology, 3rd ed. New York: Raven Press, 1994.Google Scholar
9World Health Organization: Hydrogen Cyanide and Cyanides: Human Health Aspects. Concise International Chemical Assessment Document 61. World Health Organization: Geneva, 2004.Google Scholar
10Baskin, SI, Brewer, TG: Cyanide Poisoning. In: Textbook of Military Medicine: Medical Aspects of Chemical and Biological Warfare. The Virtual Naval Hospital. Available at http://www.vnh.org/MedAspChemBioWar/chapters/chap-ter_10.hrm. Accessed 22 February 2004.Google Scholar
11Hall, A, Rumack, BH: Clinical toxicology of cyanide. Ann Emerg Med 1986;15:10671074.CrossRefGoogle ScholarPubMed
12Borron, SW, Baud, FJ: Toxicity, cyanide. February 2003. Available at http://www.emedicine.com/emerg/topic118.htm. Accessed 13 January 2004.Google Scholar
13National Safety Council: Hydrogen cyanide chemical backgrounder. Available at http://www.nsc.org/library/chemical/Hydrocya.htm. Accessed 13 January 2006.Google Scholar
14Mégarbane, B, Delahaye, A, Goldgran-Tolédano, D et al. , : Antidotal treatment of cyanide poisoning. J Chin Med Assoc 2003;66:193203.Google ScholarPubMed
15US Department of Health, Education, and Welfare; National Institute for Occupational Safety and Health: Occupational Exposure to Hydrogen Cyanide and Cyanide Salts. DHEW (NIOSH) Publication No. 77–108. US Department of Health Education and Welfare: Washington DC. October 1976.Google Scholar
16Dwiggins, GA: Can I go to jail? A review of criminal liability for workplace injury or death. Appl Occup Environ Hyg 2002;17:237241.CrossRefGoogle ScholarPubMed
17Watson, WA, Litovitz, TL, Rodgers, GC et al. , : 2002 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 2003;21:353421.CrossRefGoogle Scholar
18Agency for Toxic Substances and Disease Registry. US Department of Health and Human Services, Public Health Service: Cyanide toxicity. Am Fam Phys 1993;48:107114.Google Scholar
19Chemical Casualty Care Division, Aberdeen Proving Ground, MD. Cyanide AC, CK. United States Army Medical Research Institute of Chemical Defense: Medical Management of Chemical Casualties Handbook, 3rd edition. The Virtual Naval Hospital Project, 1997-2004. Available at http://www.vnh.org/CHEMCASU/03Cyanide.html. Accessed 13 January 2004.Google Scholar
20Kulig, K: Cyanide antidotes and fire toxicology. N Engl J Med 1991;325:18011802.CrossRefGoogle ScholarPubMed
21Hall, AH, Kulig, KW, Rumack, BH: Suspected cyanide poisoning in smoke inhalation: Complications of sodium nitrite therapy. Journal de Toxicologie Clinique et Expérimentale 1989;9:39.Google ScholarPubMed
22Kerger, H, Dodidou, P, Passani-Kruppa, D et al. , : Excessive methaemoglobinaemia and multi-organ failure following 4-DMAP antidote therapy. Resuscitation 2005;66:231235.CrossRefGoogle ScholarPubMed
23Fortin, JL, Ruttimann, M, Domanski, L et al. , : Hydroxocobalamin: treatment for smoke inhalation-associated cyanide poisoning. Meeting the needs of fire victims. JEMS 2004;29:suppl 1821.Google ScholarPubMed
24Houeto, P, Borron, SW, Sandouk, P et al. , : Pharmacokinetics of hydroxocobalamin in smoke inhalation victims. J Toxicol Clin Toxicol 1996;34:397404.CrossRefGoogle ScholarPubMed
25Borron, SW, Barriot, P, Imbert, M et al. , : Hydroxocobalamin for empiric treatment of smoke inhalation-associated cyanide poisoning: Results of a prospective study in the prehospital setting. Ann Emerg Med 2005;46:s77. Abstract.CrossRefGoogle Scholar
26Borron, S, Mégarbane, B, Baud, FJ: Hydroxocobalamin is an effective antidote in severe acute cyanide poisoning in man. Int J Toxicol 2004;23:399400.Google Scholar
27Gourlain, H, Caliez, C., Laforge, M et al. , : Study of the mechanisms involved in hydroxocobalamin interference with determination of some biochemical parameters. Ann Biol Clin 1994;52:121124.Google ScholarPubMed
28Curry, SC, Connor, DA, Raschke, RA: Effect of the cyanide antidote hydroxocobalamin on commonly ordered serum chemistry studies. Ann Emerg Med 1994;24:6567.CrossRefGoogle ScholarPubMed
29Heyworth-Smith, D, Hogan, PG: Allergy to hydroxycobalamin, with tolerance of cyanocobalamin. MJA 2002;177:162163.Google ScholarPubMed
30Branco-Ferreira, M, Clode, MH, Pereria-Barbosa, MA et al. , : Anaphylactic reaction to hydroxycobalamin. Allergy 1997;52:118119.CrossRefGoogle ScholarPubMed
31Vidal, C., Lorenzo, A: Anaphylactoid reaction to hydroxycobalamin with tolerance of cyanocobalamin. Postgrad Med J 1998;74:702.CrossRefGoogle ScholarPubMed